Stem Cell Cancer


Cancer When transplanted into an animal host, stem cells (CSCs), a tiny fraction of cells within tumours, are capable of self-renewal, differentiation, and tumorigenicity. To recognise and enrich CSCs, a range of cell surface markers, including CD44, CD24, and CD133, are frequently utilised.

Some cancers, such as leukaemia, lymphoma, and myeloma, can be treated by bone marrow or stem cell transplantation. High dose chemotherapy and occasionally radiotherapy are used to treat them. They may also be referred to as intense treatment, stem cell rescue, or bone marrow rescue. At 20 years after transplantation, the study cohort's estimated survival rate was 80.4% (95% CI, 78.1% to 82.6%). Age at transplantation was inversely linked with survival after five years.


 


  • Chemotherapy
  • Radiotherapy

Related Conference of Stem Cell Cancer

December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Paris, France
February 05-06, 2026

11th World Conference on Breast and Cervical Cancer

Paris, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
September 29-30, 2026

5th Experts Meeting on Cancer Medicine, Radiology & Treatment

Aix-en-Provence, France

Stem Cell Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in